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Ocular complications in dengue fever are uncommon but may result in
visual loss. The authors report the first documented case of a patient with
dengue fever who presented with simultaneous bilateral acute angle closure
glaucoma. The disease was confirmed by specific serological tests. Despite
the treatment, severe visual impairment occurred in this case.
ABSTRACT
RELATOS DE CASOS
INTRODUCTION
Dengue fever (DF), the most important mosquito-borne viral disease
affecting humans, occurs in over 100 countries, with an estimated 100
million cases per year and more than 2.5 billion people at risk worldwide(1). It
has emerged as a global public health problem in the past several decades
and is now endemic in most tropical and subtropical areas of Central and
South America, Southest Asia, the Western Pacific, Africa, and the Eastern
Mediterranean(1-2).
Classic DF is a self-limiting, influenza-like illness caused by any of the
four serotypes (DEN 1-4) of dengue virus. Dengue hemorrhagic fever (DHF)
is a more severe form of the disease characterized by multisystem hemor-
rhagic manifestations, thrombocytopenia, increased vascular permeability,
and plasma leakage. The early phase of DHF is indistinguishable from DF.
The death rate for untreated DHF can be as high as 10-20% in places where
emergency supportive treatment with intravenous fluids and platelet repla-
cement is not readily accessible(3).
In Brazil, more than a million cases were reported since the reintro-
duction of dengue in 1982(4). The state of Ceará in the Northeast region of
Brazil has had successive dengue epidemics that involved dengue virus
serotypes DEN-1, DEN-2, and DEN-3. In 2006, there were 25,569 confirmed
cases of dengue in this state and 172 fulfilled the World Health Organization
criteria for DHF(5). Usually, epidemics are more intense in cities, which is
attributed to favorable epidemiological characteristics of rapidly growing
urban agglomerations such as crowding, poor housing, as well as the
existence of many putative breeding sites such as disposable containers,
bottles and used tires(6).
The principal vector of dengue infection is the hematophagous mosqui-
to Aedes aegypti, a domestic-peridomestic insect. Man is the major verte-
brate host and is the most important means of dispersion of the illness. To
date, only this mosquito species has been associated with viral transmis-
sion in Brazil, despite the presence of Aedes albopictus, a competent vector
in Asia(7).
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Ophthalmic complications associated with DF and DHF
have not been classically described. Within the ophthalmic
community, this complication is being observed more fre-
quently in recent times. However, only a few isolated case
reports have been published(8-13). We describe a patient with
DF who developed bilateral acute angle closure glaucoma
(AACG).
CASE REPORT
A previously healthy 67-year-old woman was admitted to
the hospital with sudden loss of vision, intense ocular pain,
lacrimation, photophobia, and redness of both eyes. She re-
ported a 3-day history of fever, headache, nausea, and vo-
miting. Her previous medical and ocular history was unremar-
kable. Her physical examination revealed fever of 38ºC and
mild dehydration. No rash, jaundice or neck stiffness was
noted. Blood test revealed a hemoglobin rate 12.9 g/dL, leu-
kopenia (4.0 x 109/L), and thrombocytopenia (100 x 109/L).
Alanine aminotransferase (ALT)/aspartate aminotransferase
(AST) were 125/65 IU/L. Blood sugar, creatinine, electrolytes
were normal.
In view of the severity of her visual symptoms she was
referred to the Emergency Ophthalmology Department. Oph-
thalmological examination revealed that both eyes had visual
acuity of hand motions, and elevated intraocular pressure
(IOP) (60 mmHg in the right eye (RE) and 54 mmHg in the left
eye (LE)), by applanation. Both eyes were injected with cor-
neal edema, shallow anterior chamber, iris atrophy, and fixed
moderately dilated pupils (Figure 1). Both crystalline lenses
exhibited nuclear sclerosis 2+ and glaucomflecken, gonios-
copy showed closed angles. No angle structures could be
seen beyond Schwalbe’s line, even on indentation, however,
there were no goniosynechiae. Fundoscopy was not clear.
The axial length was 22.13 mm and 22.12 mm in the RE and LE,
respectively. B-Scan ultrasonography showed normal poste-
rior segments in both eyes. A diagnosis of bilateral AACG
was made and she was treated with 20% intravenous mannitol
followed by topical 2% pilocarpine q.i.d., 0.5% timolol b.i.d.,
and 1% prednisolone acetate q.i.d. to both eyes. The IOP
reduced to 22 and 20 mmHg in right and left eyes respectively
and bilateral laser iridotomies were performed.
On the following day her symptoms were present but
improving. Computed tomography of the brain was normal.
Blood tests showed a worsening leukopenia (3 x109/L) as well
as thrombocytopenia (80 x 109/L). During hospital stay, she
also was given intravenous and oral fluids and paracetamol.
Five days later she was almost asymptomatic with a platelet
count of 108 x 109/L and was discharged. Specific serological
tests (IgG and IgM) confirmed the dengue infection. She was
advised to continue on timolol, pilocarpine and predni-
solone eye drops for further 14 days. The patient’s ocular
findings improved gradually over the subsequent month.
However, her visual symptoms had still not completely disap-
peared and visual acuity was 20/200 in both eyes. Her RE IOP
was 20 mmHg and left was 19 mmHg without any treatment.
The eye fundus exploration without dilatation did not exhibit
significant alterations.
DISCUSSION
DF and DHF continue to be a global challenge. There is no
specific treatment available nor any immediate prospect of a
vaccine, and the mosquito control measures in most of the
hyperendemic areas are inadequate(14).
Ophthalmic complications in dengue infections are rare,
but there has been an increasing number of cases reported in
recent literature(8-14). The main ocular findings include sub-
conjunctival hemorrhages, macular edema and blot hemor-
rhages. Less common features include exudative retinal deta-
chment, cotton wool spots, and anterior uveitis. A majority of
patients were reported to have residual visual impairment(13-14).
Figure 1 - Conjunctival hyperemia, corneal edema, iris atrophy, and fixed moderately dilated pupils are seen in the right (A) and left (B) eyes
BA
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The pathogenesis of ocular complications in dengue fever
is not fully understood. Thrombocytopenia in severe dengue
may predispose towards hemorrhage. However, clinical pre-
sentation and behavior of these complications can suggest an
immunogenic etiology rather than an infective one(15). Other
postulates include viral mutations, viral virulence and host
susceptibility. Viral genetic mutations have been demonstra-
ted to occur within the various serotypes, however the biolo-
gic effects induced by these mutations are as yet uncharac-
terized(15-16). More research is still needed to evaluate the patho-
genesis of these ocular manifestations.
Bistis (1929, apud Richardson(17)) published an article in
1929 concerning the epidemic of dengue in Athens, in which
he said that iritis, glaucoma, and retrobulbar neuritis had been
mentioned as complications. During the same epidemic Anar-
gyros (1929, apud Richardson(17)) reported five cases with
ocular complications. In one, glaucoma of the left eye appea-
red on the fourth and last day of the fever, simultaneously
with the appearance of the exanthem, and two days later there
was a less severe attack of glaucoma in the right eye. Iridec-
tomy was done, first in the left, then in the right eye. Another
patient, aged fifty-four years, had two years previously lost
the sight of the right eye from glaucoma. The eye had remai-
ned painless until convalescence from dengue took place,
when the conjunctiva became injected and there was intense
pain. The eye was enucleated and the vitreous body was
found to be full of blood clots.
Gabrielides (1929, apud Richardson(17)) observed two ca-
ses of angle closure glaucoma during dengue infection in wo-
men aged sixty and fifty-four years respectively. In the first
case symptoms appeared on the third day; in the second case
the symptoms, with the complete loss of vision, appeared on
the fourth day. Notwithstanding intensive treatment, the glau-
comatous phenomena, and especially the pupillary dilatation,
persisted.
Bilateral simultaneous acute angle closure is a rare entity,
infrequently reported after psychotropic drug intake(18), gene-
ral anesthesia(19), or snake bite(20). To the best of our knowled-
ge, no cases of bilateral simultaneous acute angle closure
glaucoma related to dengue fever have been reported before.
Our patient presented with bilateral sudden loss of vision,
elevated IOP, shallow anterior chamber, corneal edema, and
dilated pupils during a febrile illness. The diagnosis of dengue
fever was suspected based on leuko- and thrombocytopenia,
elevated serum transaminase levels plus dehydration, and this
diagnosis was confirmed by serological tests. Longer follow-
up will be required to determine whether this functional visual
loss is permanent.
Acute angle closure glaucoma is a potentially blinding
side effect of a number of local and systemic drugs, including
adrenergic, both anticholinergic and cholinergic, antidepres-
sant and antianxiety, sulfa-based, and anticoagulant agents(21).
Although we had not identified the use of these substances
by the patient, increased vigilance in such patients treated
with these drugs may reduce the risk of this adverse effect.
In conclusion, although dengue fever is considered to be
rarely associated with ocular manifestations, with increasing
epidemicity and co-circulation of multiple dengue serotypes,
the occurrence of DF and DHF is set to rise. Similarly we expect
to see an increase in this newly emergent facet of dengue
ophthalmic morbidity. A heightened awareness of dengue-
related ophthalmic complications among clinicians involved
in the care of patients with dengue would facilitate prompt
referral for ophthalmologic assessment and management. In
addition, bilateral acute angle closed glaucoma is a severe
complication that may occur in individuals at risk for angle
closure glaucoma with DF. Patients with periorbital pain and
visual symptoms should be examined for angle closure glau-
coma attack in both eyes.
RESUMO
Complicações oculares são incomuns na dengue, mas podem
resultar em perda visual. Os autores relatam o primeiro caso de
um paciente com dengue que apresentou glaucoma agudo
bilateral. Testes sorológicos confirmaram a doença. Apesar
do tratamento, houve perda visual grave.
Descritores: Dengue/complicações; Glaucoma; Pressão intra-
ocular/etiology; Brasil; Relatos de casos [Tipo de publicação]
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